|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Interest income, net | |||
| Other income | |||
| Total other income, net | |||
| Net loss | |||
| Net loss per share attributable to common stockholders - basic (in USD per share) | |||
| Net loss per share attributable to common stockholders - diluted (in USD per share) | |||
| Weighted-average shares used to compute net loss per share attributable to common stockholders - basic (in shares) | |||
| Weighted-average shares used to compute net loss per share attributable to common stockholders - diluted (in shares) |
Loading...
